
New approaches to research into systemic sclerosis
A research team at TWINCORE was able to establish that TLR8 influences the formation of disease-relevant cytokines.
Patients with chronic rheumatic diseases have an increased risk of infection due to severe inflammation. This project investigates inflammation in various tissues, particularly in systemic sclerosis, in order to develop targeted therapies.
Immunomodulatory drugs for rheumatic diseases specifically influence immune cells and messenger substances. This project investigates their effect on immune responses in order to find individually suitable therapies.
Immunomodulatory drugs can have systemic side effects. This project is testing nanocarriers that deliver drugs specifically into myeloid immune cells in order to reduce side effects and increase the local effect.
A research team at TWINCORE was able to establish that TLR8 influences the formation of disease-relevant cytokines.
How B cells recognise new variants of SARS-CoV-2
Communication between immune cells determines response to vaccination
New transport route for antibiotics directly into infected cells
TWINCORE scientists decode a new camouflage mechanism of cytomegalovirus
Clinician scientist Theresa Graalmann starts her own group at TWINCORE